Exploring Synergy in Combinations of Tumor-Derived Vaccines That Harbor 4-1BBL, OX40L, and GM-CSF

Recent studies have demonstrated that combination of modulatory immune strategies may potentiate tumor cell elimination. Most strategies rely on the use of monoclonal antibodies that can block cell surface receptors to overcome tumor-induced immunosuppression or acting as costimulatory ligands to bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Manrique-Rincón, Andrea J., Beraldo, Camila M., Toscaro, Jessica M., Bajgelman, Marcio C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610681/
https://www.ncbi.nlm.nih.gov/pubmed/28974950
http://dx.doi.org/10.3389/fimmu.2017.01150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610681/
https://www.ncbi.nlm.nih.gov/pubmed/28974950
http://dx.doi.org/10.3389/fimmu.2017.01150

Ejemplares similares